Iron and Alzheimer's disease: new mechanisms, biomarkers and therapeutics [ 2020 - ]

Research Grant

Researchers: Dr Scott Ayton (Principal investigator)

Brief description The disappointment in failed Alzheimer’s drug trials has fuelled a renewed effort to rethink this disease. Based on my recent clinical and laboratory findings, I have identified a pathway involving iron that might be driving Alzheimer’s disease progression. I will investigate this using laboratory models, and in patients, for the purpose of developing new diagnostics. Importantly, these data are foundational to a clinical trial that I am currently performing.

Funding Amount $437,036.00

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF